Top insider trades (week of Jan 20)

Welcome to this week’s edition of CEO Watcher. This is the only tool that tracks the returns of insiders so we know which insider trades are worth copying.

This week we found:

• $MRAI popped 22% in the three hours after we found it

• The Global Counsel at $TLRY bought the stock

• and more…

Have a great weekend and thanks for reading!

Connor

💰 Previous Winner

We had another super quick winner in CEO Watcher Premium this week when we found the CEO at $MRAI made his largest purchase that was over 3x larger than any other purchase.

The stock opened at $1.03 and jumped to $1.26 by noon the same day. +22% in just 3 hours is pretty good!

Upgrade to CEO Watcher Premium to get the top insider trades as soon as they happen.

👀 Top Insider Trades this Week

🥇 Global General Counsel at Tilray Brands, Inc. ($TLRY)

The Global General Counsel purchased 7,200 shares at $1.98/share ($14,256.00 total) which increased their holdings by 3.8%. The current price is $2.00 (+1%). (trade link)

Historic Returns
1m returns: 54% weighted | 31% median | 67% win rate (4/6)
3m returns: 51% weighted | 42% median | 67% win rate (4/6)
6m returns: 81% weighted | 56% median | 67% win rate (4/6)
1y returns: 87% weighted | 27% median | 67% win rate (4/6)

Rating: 8
Why: A pretty compelling purchase, but the size is fairly small which keeps the score from being higher.

🥈 10% Owner at KalVista Pharmaceuticals, Inc. ($KALV)

The 10% Owner purchased 19,599 shares at $12.73/share ($249K total) which increased their holdings by 0.5%. The current price is $12.41 (-2.5%). (trade link)

Historic Returns
1m returns: 86% weighted | 17% median | 100% win rate (4/4)
3m returns: 46% weighted | 30% median | 50% win rate (2/4)
6m returns: 19% weighted | 3% median | 50% win rate (2/4)
1y returns: 37% weighted | 20% median | 50% win rate (2/4)

Note: The third week in a row they have bought the stock, but the Chief Scientific Officer also sold some stock last week. We own this in the CEO Watcher Portfolio.

Rating: 8
Why: They’ve been bought a ton of the stock over the last few weeks. The main thing preventing the score from being higher is that the Chief Scientific Officer has been selling the stock during this time.

🥉 Executive VP of R&D at AEHR TEST SYSTEMS ($AEHR)

The Executive VP of R&D purchased 3,000 shares at $17.87/share ($53,600.10 total) which increased their holdings by 44.6%. The current price is $16.60 (-7%). (trade link)

Historic Returns
N/A. This is their first purchase

Rating: 6
Why: A sizable first purchase that increased their holdings by 44%. Not having any historic returns prevents us from rating it any higher

Get the insider trades as soon as they happen

By upgrading to CEO Watcher Premium, you get the top insider trades as soon as they happen.

Each morning you get an email with the best insider buys and sells.

CEO Watcher Premium perks:

• Daily email with top insider buys/sells

• Access to the CEO Watcher Premium Portfolio. I took $10,000 out of my retirement account to invest in the stocks we find in the CEO Watcher and Yellowbrick Road newsletters. Help me turn that $10k into $100k (or just watch me lose it all).

• Full access to Yellowbrick Road Premium

Just one profitable trade will pay for a full year (or more) of CEO Watcher Premium. And, I’ll even make a deal with you. If you upgrade to CEO Watcher Premium and don’t get 10x more value than what you paid, I’ll give you your money back at any time with no questions asked.